Abstract
Antibodies are used extensively in diagnostics and as therapeutic agents. Achieving high-affinity binding is important for expanding detection limits, extending dissociation half-times, decreasing drug dosages and increasing drug efficacy. However, antibody-affinity maturation in vivo often fails to produce antibody drugs of the targeted potency1, making further affinity maturation in vitro by directed evolution or computational design necessary. Here we present an iterative computational design procedure that focuses on electrostatic binding contributions and single mutants. By combining multiple designed mutations, a tenfold affinity improvement to 52 pM was engineered into the anti–epidermal growth factor receptor drug cetuximab (Erbitux), and a 140-fold improvement in affinity to 30 pM was obtained for the anti-lysozyme model antibody D44.1. The generality of the methods was further demonstrated through identification of known affinity-enhancing mutations in the therapeutic antibody bevacizumab (Avastin) and the model anti-fluorescein antibody 4-4-20. These results demonstrate computational capabilities for enhancing and accelerating the development of protein reagents and therapeutics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Foote, J. & Eisen, H.N. Kinetic and affinity limits on antibodies produced during immune responses. Proc. Natl. Acad. Sci. USA 92, 1254–1256 (1995).
Desjarlais, J.R. & Handel, T.M. De novo design of the hydrophobic cores of proteins. Protein Sci. 4, 2006–2018 (1995).
Dahiyat, B.I. & Mayo, S.L. De novo protein design: fully automated sequence selection. Science 278, 82–87 (1997).
Kuhlman, B. et al. Design of a novel globular protein fold with atomic-level accuracy. Science 302, 1364–1368 (2003).
Reina, J. et al. Computer-aided design of a PDZ domain to recognize new target sequences. Nat. Struct. Biol. 9, 621–627 (2002).
Looger, L.L., Dwyer, M.A., Smith, J.J. & Hellinga, H.W. Computational design of receptor and sensor proteins with novel functions. Nature 423, 185–190 (2003).
Cochran, F.V. et al. Computational de novo design and characterization of a four-helix bundle protein that selectively binds a nonbiological cofactor. J. Am. Chem. Soc. 127, 1346–1347 (2005).
Havranek, J.J. & Harbury, P.B. Automated design of specificity in molecular recognition. Nat. Struct. Biol. 10, 45–52 (2003).
Bolon, D.N., Grant, R.A., Baker, T.A. & Sauer, R.T. Specificity versus stability in computational protein design. Proc. Natl. Acad. Sci. USA 102, 12724–12729 (2005).
Ashworth, J. et al. Computational redesign of endonuclease DNA binding and cleavage specificity. Nature 441, 656–659 (2006).
Joachimiak, L.A., Kortemme, T., Stoddard, B.L. & Baker, D. Computational design of a new hydrogen bond network and at least a 300-fold specificity switch at a protein-protein interface. J. Mol. Biol. 361, 195–208 (2006).
Ambroggio, X.I. & Kuhlman, B. Computational design of a single amino acid sequence that can switch between two distinct protein folds. J. Am. Chem. Soc. 128, 1154–1161 (2006).
Dwyer, M.A., Looger, L.L. & Hellinga, H.W. Computational design of a biologically active enzyme. Science 304, 1967–1971 (2004).
Lassila, J.K., Keeffe, J.R., Oelschlaeger, P. & Mayo, S.L. Computationally designed variants of Escherichia coli chorismate mutase show altered catalytic activity. Protein Eng. Des. Sel. 18, 161–163 (2005).
Korkegian, A., Black, M.E., Baker, D. & Stoddard, B.L. Computational thermostabilization of an enzyme. Science 308, 857–860 (2005).
Dixon, R.W. et al. Theoretical and experimental studies of biotin analogues that bind almost as tightly to streptavidin as biotin. J. Org. Chem. 67, 1827–1837 (2002).
Song, G. et al. Rational design of intercellular adhesion molecule-1 (ICAM-1) variants for antagonizing integrin lymphocyte function-associated antigen-1-dependent adhesion. J. Biol. Chem. 281, 5042–5049 (2006).
Sood, V.D. & Baker, D. Recapitulation and design of protein binding peptide structures and sequences. J. Mol. Biol. 357, 917–927 (2006).
Clark, L.A. et al. Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design. Protein Sci. 15, 949–960 (2006).
Sato, J.D. et al. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol. Biol. Med. 1, 511–529 (1983).
Boder, E.T., Midelfort, K.S. & Wittrup, K.D. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. Natl. Acad. Sci. USA 97, 10701–10705 (2000).
Midelfort, K.S. & Wittrup, K.D. Context-dependent mutations predominate in an engineered high-affinity single chain antibody fragment. Protein Sci. 15, 324–334 (2006).
Presta, L.G. et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 57, 4593–4599 (1997).
Chen, Y. et al. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. J. Mol. Biol. 293, 865–881 (1999).
Joughin, B.A., Green, D.F. & Tidor, B. Action-at-a-distance interactions enhance protein binding affinity. Protein Sci. 14, 1363–1369 (2005).
Selzer, T., Albeck, S. & Schreiber, G. Rational design of faster associating and tighter binding protein complexes. Nat. Struct. Biol. 7, 537–541 (2000).
Levy, R.M., Zhang, L.Y., Gallicchio, E. & Felts, A.K. On the nonpolar hydration free energy of proteins: surface area and continuum solvent models for the solute-solvent interaction energy. J. Am. Chem. Soc. 125, 9523–9530 (2003).
Gallicchio, E., Zhang, L.Y. & Levy, R.M. The SGB/NP hydration free energy model based on the surface generalized born solvent reaction field and novel nonpolar hydration free energy estimators. J. Comput. Chem. 23, 517–529 (2002).
Gallicchio, E. & Levy, R.M. AGBNP: an analytic implicit solvent model suitable for molecular dynamics simulations and high-resolution modeling. J. Comput. Chem. 25, 479–499 (2004).
Wagoner, J.A. & Baker, N.A. Assessing implicit models for nonpolar mean solvation forces: the importance of dispersion and volume terms. Proc. Natl. Acad. Sci. USA 103, 8331–8336 (2006).
Acknowledgements
We thank S.L. Sazinsky for the gift of the 404SG material, and D. Lipovsek and R.T. Sauer for comments on the manuscript. This work was supported by a National Science Foundation Graduate Fellowship to S.M.L. and grants from the National Institutes of Health (CA96504 and GM65418).
Author information
Authors and Affiliations
Contributions
B.T. oversaw all computational aspects of the work, and K.D.W. oversaw all experimental aspects of the work. S.M.L. developed and adopted the design methods and software and carried out all computational and experimental studies. The authors as a group interpreted the results of the calculations and selected the mutants to create experimentally. S.M.L. drafted the manuscript, and all authors contributed to its editing.
Corresponding authors
Supplementary information
Supplementary Text and Figures
Supplementary Table 1–3, Supplementary Methods, Supplementary Figures 1–4 (PDF 131 kb)
Rights and permissions
About this article
Cite this article
Lippow, S., Wittrup, K. & Tidor, B. Computational design of antibody-affinity improvement beyond in vivo maturation. Nat Biotechnol 25, 1171–1176 (2007). https://doi.org/10.1038/nbt1336
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1336
This article is cited by
-
Engineering protein-based therapeutics through structural and chemical design
Nature Communications (2023)
-
High-throughput analysis system of interaction kinetics for data-driven antibody design
Scientific Reports (2023)
-
The effect of mutations on binding interactions between the SARS-CoV-2 receptor binding domain and neutralizing antibodies B38 and CB6
Scientific Reports (2022)
-
Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences
Scientific Reports (2021)
-
Investigation of major amino acid residues of anti-norfloxacin monoclonal antibodies responsible for binding with fluoroquinolones
Scientific Reports (2021)